Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy

Nature Medicine

Volumn 8, Issue 7, 2002, Pages 673-680

  Greene, Warner C ^a   Peterlin, B Matija ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; CYCLOPHILIN A; GAG PROTEIN; GLYCOPROTEIN GP 120; GUANINE NUCLEOTIDE BINDING PROTEIN; LECTIN; MITOGEN ACTIVATED PROTEIN KINASE; NEF PROTEIN; VIRUS DNA; VIRUS PROTEIN;

CELL CYCLE; CELL DEATH; DENDRITIC CELL; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION CONTROL; MUTATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; T LYMPHOCYTE; TRANSCRIPTION INITIATION; VIRION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CELLS; HIV; HIV INFECTIONS; HUMANS; NUCLEAR PORE; VIRUS REPLICATION;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0036062256     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0702-673     Document Type: Review

References (100)

1. Current strategies in the treatment of HIV infection
2. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells
3. Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells
4. A block to human immunodeficiency virus type 1 assembly in murine cells
5. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein
6. Tat transactivation: A model for the regulation of eukaryotic transcriptional elongation
7. Retroviruses as model systems for the study of nuclear RNA export pathways
8. The plasma membrane as a combat zone in the HIV battlefield
9. HIV entry and its inhibition
10. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts
11. Lipid rafts and HIV-1: From viral entry to assembly of progeny virions
12. Structure of an HIV gp 120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
13. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
14. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
15. Global distribution of the CCR5 gene 32-basepair deletion
16. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus
17. Lipid rafts and HIV pathogenesis: Host membrane cholesterol is required for infection by HIV type 1
18. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
19. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection
20. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin
21. Endocytic entry of HIV-1
22. Identification of three major phosphorylation sites within HIV-1 capsid. Role of phosphorylation during the early steps of infection
23. Specific incorporation of cyclophilin A into HIV-1 virions
24. Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions
25. Role of Vif in stability of the human immunodeficiency virus type 1 core
26. Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4
27. Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture
28. Characterization of HIV replication complexes early after cell-to-cell infection
29. Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton
30. Evidence for a newly discovered cellular anti-HIV-1 phenotype
31. Human immunodeficiency virus type 1 preintegration complexes: Studies of organization and composition
32. Accumulation and intranuclear distribution of unintegrated human immunodeficiency virus type 1 DNA
33. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: Interference with early steps of viral replication
34. Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes
35. Transport routes through the nuclear pore complex
36. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
37. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells
38. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells
39. HIV-1 genome nuclear import is mediated by a central DNA flap
40. Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr
41. HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells
42. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection
43. A novel nuclear export activity in HIV-1 matrix protein required for viral replication
44. The barrier-to-autointegration protein is a host factor for HIV type 1 integration
45. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA
46. Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection
47. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts
48. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation
49. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product
50. Control of RNA initiation and elongation at the HIV-1 promoter
51. Phosphorylation meets ubiquitination: The control of NF-κB activity
52. Generic signals and specific outcomes: Signaling through Ca2+, calcineurin, and NF-AT
53. NFκB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II
54. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA
55. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II
56. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 Tat-P-TEFb complex to TAR RNA
57. The 7SK small nuclear RNA inhibits the CDK9/cyClin. T1 kinase to control transcription
58. HIV Rev-dependent binding of SF2/ASF to the Rev response element: Possible role in Rev-mediated inhibition of HIV RNA splicing
59. Cellular protein modulates effects of human immunodeficiency virus type 1 Rev
60. HIV-1 structural gene expression requires binding of the Rev. trans-activator to its RNA target sequence
61. Rev and the fate of pre-mRNA in the nucleus: Implications for the regulation of RNA processing in eukaryotes
62. Role of the SH3-ligand domain of simian immunodeficiency virus Nef in interaction with Nef-associated kinase and simian AIDS in rhesus macaques
63. Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators
64. CD4 down-modulation by human immunodeficiency virus type 1 Nef correlates with the efficiency of viral replication and with CD4(+) T-cell depletion in human lymphoid tissue ex vivo
65. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner
66. Nef increases infectivity of HIV via lipid rafts
67. Structure-function relationships in HIV-1 Nef
68. The Nef protein of HIV-1 associates with rafts and primes T cells for activation
69. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef
70. CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor
71. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif
72. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain
73. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
74. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules
75. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell
76. HIV-1 Nef associated PAK and P13-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals
77. Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis
78. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle
79. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo
80. Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr
81. HIV-1 gag proteins: Diverse functions in the virus life cycle
82. Organization of immature human immunodeficiency virus type 1
83. Identification of a host protein essential for assembly of immature HIV-1 capsids
84. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1
85. Plasma membrane rafts play a critical role in HIV-1 assembly and release
86. Identification of retroviral late domains as determinants of particle size
87. A role for ubiquitin ligase recruitment in retrovirus release
88. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding
89. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag)
90. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-J
91. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes
92. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1
93. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120
94. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization
95. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest
96. Unexpectedly high levels of HIV-1 RNA and protein synthesis in a cytocidal infection
97. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice
98. Flavopiridol inhibits P-TEFb and blocks HIV-1 replication
99. Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA
100. Leptomycin B is an inhibitor of nuclear export: Inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA